ClinicalTrials.gg
RecruitingNCT07351305T3 for PTSDUpdated Aug 28, 2026

Non-Trauma Intervention to Treat PTSD for Veterans and Service Members Suffering From a TBI

An interventional study of Non-Trauma Treatment for TBI and PTSD in PTSD, Post Traumatic Stress Disorder and Traumatic Brain Injury, sponsored by The University of Texas Health Science Center at San Antonio. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by The University of Texas Health Science Center at San Antonio · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Stress Disorders, Post-Traumatic by The University of Texas Health Science Center at San Antonio — 8 open to participants now, 8 under way, none of them phase 3. Stress Disorders, Post-Traumatic · The University of Texas Health Science Center at San Antonio.

Planned enrollment
16th of 25
30 · median 49
Started
2026
with 3 others
No phase
20 of 27
6 open now
Registered
24th of 27
by date

Among the 27 studies in Stress Disorders, Post-Traumatic by The University of Texas Health Science Center at San Antonio, this one is the 16th largest by planned enrollment of the 25 interventional ones that give a count, is one of 4 that started in 2026, is one of 20 with no phase, and was the 24th registered.

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

8 of the 27 studies in Stress Disorders, Post-Traumatic by The University of Texas Health Science Center at San Antonio are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Stress Disorders, Post-Traumatic by The University of Texas Health Science Center at San Antonio, or all of them as a file.
02

Study summary

The investigators want to test a treatment for posttraumatic stress disorder (PTSD) especially designed for military veterans and service members with mild or moderate traumatic brain injuries (TBI) and PTSD. The treatment will include individual psychotherapy sessions to manage PTSD.

Read the detailed description

The objective of this study is to test a non-trauma intervention for PTSD tailored to military veterans and service members with TBI called Non-Trauma Treatment for TBI and comorbid PTSD (T3 PTSD).

Aim1:

Conduct a pilot study of the non-trauma intervention for comorbid TBI and PTSD in a sample of n = 20 veterans and service members seeking treatment at Fort Hood, Texas.

Aim2:

Establish the acceptability and feasibility of the non-trauma intervention in service members and veterans.

03

Conditions studied

  • PTSD
  • Post Traumatic Stress Disorder
  • Traumatic Brain Injury

Keywords

  • Non-trauma intervention
  • Veterans
  • Service Members
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Ability of participant to understand and the willingness to sign a written document based on interviewer assessment and clinical judgement.
  2. Any veteran or active duty service member (age 18 or above) diagnosed with mild or moderate TBI as determined by the Ohio State University Brain Injury Identification Method
  3. Participant meets diagnostic criteria for PTSD based on Clinician-Administered PTSD Scale (CAPS-5) interview as described by the National Center for PTSD which includes at least one Criterion B symptom, one Criterion C symptom, two Criterion D symptoms, and two Criterion E symptoms as well as meeting Criterions F and G.
  4. Ability to read, write, and speak English based on interviewer assessment and clinical judgement.

Exclusion criteria

Exclusion Criteria:

  1. Participant is actively engaged in a behavioral intervention primarily targeting PTSD.
  2. Participant has a psychiatric problem that warrants immediate treatment as indicated in the electronic health record, flagged during testing, or confirmed by a clinician through screening or review of clinical notes.
  3. Participant demonstrates significant cognitive impairment that could impact treatment adherence/benefit based on interviewer assessment and clinical judgement.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Active duty service members and veterans seeking clinical care for TBI

    Male and female active duty service members and veterans at least 18 years of age who are seeking clinical care for mild or moderate Traumatic Brain Injury (TBI) symptoms at the Intrepid Spirit Center located on Fort Hood who also have a co-occurring diagnosis of PTSD

    Behavioral: Non-Trauma Treatment for TBI and PTSD

Interventions

  • BehavioralNon-Trauma Treatment for TBI and PTSD

    The treatment includes 8 sessions with each session lasting approximately 45-75 minutes. Sessions will cover relaxation training, identifying stress, stress management, and problem solving.

    Also known as: T3 PTSD

06

What researchers measure

Primary outcomes

  1. PTSD Checklist-DSM-5 (PCL-5)

    The PCL-5 is a 20-item self-report measure designed to assess PTSD symptoms as defined by the DSM-5. The scoring involves summing the responses to 20 items (0 to 80) with higher scores indicating more severe PTSD.

    Time frame: Baseline to 6 months post treatment (approximately 8 months)

Secondary outcomes

  1. Credibility and Expectancy Questionnaire

    A 6-item measure that was designed to assess treatment expectancy and rationale credibility for use in clinical outcomes studies. The measure is scored on an 8-point scale with higher scores indicating higher credibility and expectancy.

    Time frame: Baseline to 2 weeks post treatment (approximately 10 weeks)

  2. Clinician Administered PTSD Scale for the Diagnostic and Statistical Manual of Mental Disorders Version 5 (DSM-5)

    The CAPS-5 contains 20-items measuring PTSD symptoms, scored on a 5-point scale with scores ranging from 0-80. Higher scores indicate greater PTSD severity.

    Time frame: Baseline to 6 months post treatment (approximately 8 months)

  3. Generalized Anxiety Disorder-7 (GAD-7)

    This 7-item measure asks participants to rate the frequency with which they have been bothered by anxiety symptoms within the past 2 weeks. Scores range from 0=not at all to 3=nearly every day, with totals from 0-21, with a higher score indicating greater anxiety.

    Time frame: Baseline to 6 months post treatment (approximately 8 months)

  4. Patient Global Impressions (PGI) Scale

    A 2-item survey where each item is scored out of 7. Total score is 0-14, where a lower score indicates less feeling of illness and greater improvement

    Time frame: 2 weeks post treatment to 6 months post treatment

  5. Alcohol Use Disorders Identification Test (AUDIT)

    A self report, 10-item survey with items scored from 0-4. Total scores range from 0-40, with a higher score indication greater alcohol consumption.

    Time frame: Baseline to 6 months post treatment (approximately 8 months)

  6. Patient Health Questionnaire-9 (PHQ-9)

    The PHQ-9 is a widely used and well-validated 9-item instrument for measuring the severity of depressive symptoms. Each item is scored from 0=not at all to 3=nearly every day giving a possible range of score from 0-27. A lower score indicates better health and well-being

    Time frame: Baseline to 6 months post treatment (approximately 8 months)

  7. Depressive Symptom Index-Suicide Subscale (DSI-SS)

    This 4-item self-report measure of suicidal ideation has excellent internal consistency and concurrent validity. Items are scored 0-3, giving a total range of 0-12, with a higher score indicating more severe suicidal ideation.

    Time frame: Baseline to 6 months post treatment (approximately 8 months)

  8. Insomnia Severity Index (ISI)

    A 7 item scale scored from 0-4 for each item. Total scores range from 0-28 with a higher score indicating worse insomnia.

    Time frame: Baseline to 6 months post treatment (approximately 8 months)

  9. Life Events Checklist-5 (LEC-5)

    The LEC-5 includes a list of 16 potentially traumatic life events commonly associated with PTSD symptoms, along with an additional item (17) that allows respondents to describe any other stressful events or experience. For each potentially traumatic life event, respondents rate their experience of that event on a 6-point nominal scale (1 = happened to me, 2 = witnessed it, 3= learned about it, 4 = part of my job, 5 = not sure, and 6 = doesn't apply). Total scores range from 6-102, with a higher score indicating less traumatic events.

    Time frame: Baseline to 6 months post treatment (approximately 8 months)

  10. Satisfaction with Therapy and Therapist Scale (STTS)

    A 12-item self-report measure with strong psychometric properties used to assess the patient's satisfaction with the therapy provided and the therapist. Even number items assess satisfaction with therapy and odd number items assess satisfaction with therapist. Scores range between 5-60 with higher scores reflective of greater satisfaction. Items are on a 5-point Likert scale that ranges from 1 = "Strong disagree" to 5 = "Strongly Agree'. Additionally, a 13th item provides an independent assessment of the patient's global improvement.

    Time frame: 2 weeks post treatment (approximately 10 weeks after the first treatment)

07

Study locations

1 of 1 sites recruiting
  • Carl R Darnall Army Medical Center
    Fort Hood, Texas 76544, United States
    Recruiting
    • Scot D Engel, PsyD · Contact254-419-4703
08

References and documents

Individual participant data

Plan to share: Yes — Individual Participant data may be shared with the research study team, the IRB, the Department of Defense representatives and state or Federal Government officials where required by law. Only deidentified data will be shared in a peer reviewed journal or in the summary results in ClinicalTrials.gov.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Public data will be shared at the end of the study after the data is analyzed.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Mar 2027, 12 months after the start.

Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 12 months is below that.

Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 9, 2026
First posted
Jan 20, 2026
StartActual
Mar 5, 2026
Primary completionEst.
Mar 2027
CompletionEst.
Aug 2027
Last update
Aug 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07351305
Collaborators
United States Department of Defense
Responsible party
Cindy McGeary (Professor, The University of Texas Health Science Center at San Antonio) — Principal investigator
First posted
Jan 20, 2026
Start date
Mar 5, 2026
Primary completion
Mar 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Aug 28, 2026

Study contacts

Cindy McGeary, PhD
Contact
mcgearyc@uthscsa.edu
210-567-5497
Cindy McGeary, PhD
principal investigator · The University of Texas Health Science Center at San Antonio

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion